- GlobeNewswire•7 hours ago
Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible ...
- Market Realist•11 hours ago
Sanofi’s (SNY) established prescription products contributed nearly 28.9% of the company's total 4Q16 revenues.
- Motley Fool•yesterday
A big phase 3 win for its up-and-coming multiple sclerosis drug could clear the path to billions of dollars in additional annual sales for this big-cap biotech stock.
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||80.19 - 81.96|
|52 Week Range||62.50 - 82.45|
|PE Ratio (TTM)||22.01|
|Dividend & Yield||3.35 (3.91%)|
|1y Target Est||N/A|